Skip to main content

Table 1 Patient characteristics

From: Drotrecogin alfa (activated): a single-centre experience of 110 patients

Age

57 ± 16

Male sex

53%

APACHE

21 ± 6

ICNARC

29 ± 7.3

Organ failures

5 (4 to 5 IQR)

Postop

38%

Back to article page

Critical Care

ISSN: 1364-8535